{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T18:19:54Z","timestamp":1779214794094,"version":"3.51.4"},"reference-count":136,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T00:00:00Z","timestamp":1757376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T00:00:00Z","timestamp":1757376000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Probiotics &amp; Antimicro. Prot."],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s12602-025-10730-z","type":"journal-article","created":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T07:08:18Z","timestamp":1757401698000},"page":"3413-3478","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Natural and synthetic antimicrobial peptides against anaerobic bacteria: A review of activities and mechanisms of action"],"prefix":"10.1007","volume":"18","author":[{"given":"Reza","family":"Ghasemi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asieh","family":"Taji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haniyeh","family":"Norouzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Koleini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad","family":"Mosadegh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6869-2301","authenticated-orcid":false,"given":"Hamid","family":"Heidari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,9]]},"reference":[{"key":"10730_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms11061474","author":"S Reissier","year":"2023","unstructured":"Reissier S, Penven M, Gu\u00e9rin F, Cattoir V (2023) Recent trends in antimicrobial resistance among anaerobic clinical isolates. Microorganisms. https:\/\/doi.org\/10.3390\/microorganisms11061474","journal-title":"Microorganisms"},{"issue":"11","key":"10730_CR2","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/j.cmi.2018.02.008","volume":"24","author":"E Nagy","year":"2018","unstructured":"Nagy E, Boyanova L, Justesen US (2018) How to isolate, identify and determine antimicrobial susceptibility of anaerobic bacteria in routine laboratories. Clin Microbiol Infect 24(11):1139\u20131148","journal-title":"Clin Microbiol Infect"},{"key":"10730_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics6040025","author":"M Gajd\u00e1cs","year":"2017","unstructured":"Gajd\u00e1cs M, Spengler G, Urb\u00e1n E (2017) Identification and antimicrobial susceptibility testing of anaerobic bacteria: rubik\u2019s cube of clinical microbiology? Antibiotics. https:\/\/doi.org\/10.3390\/antibiotics6040025","journal-title":"Antibiotics"},{"issue":"1","key":"10730_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jiac.2015.10.010","volume":"22","author":"I Brook","year":"2016","unstructured":"Brook I (2016) Spectrum and treatment of anaerobic infections. J Infect Chemother 22(1):1\u201313","journal-title":"J Infect Chemother"},{"issue":"3","key":"10730_CR5","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1128\/CMR.00092-13","volume":"27","author":"Y Achermann","year":"2014","unstructured":"Achermann Y, Goldstein EJ, Coenye T, Shirtliff ME (2014) Propionibacterium acnes: from commensal to opportunistic biofilm-associated implant pathogen. Clin Microbiol Rev 27(3):419\u2013440","journal-title":"Clin Microbiol Rev"},{"key":"10730_CR6","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.anaerobe.2016.02.007","volume":"39","author":"T Umemura","year":"2016","unstructured":"Umemura T, Hamada Y, Yamagishi Y, Suematsu H, Mikamo H (2016) Clinical characteristics associated with mortality of patients with anaerobic bacteremia. Anaerobe 39:45\u201350","journal-title":"Anaerobe"},{"issue":"5","key":"10730_CR7","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1093\/cid\/ciu395","volume":"59","author":"AN Schuetz","year":"2014","unstructured":"Schuetz AN (2014) Antimicrobial resistance and susceptibility testing of anaerobic bacteria. Clin Infect Dis 59(5):698\u2013705","journal-title":"Clin Infect Dis"},{"key":"10730_CR8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.anaerobe.2014.08.011","volume":"31","author":"AC Veloo","year":"2015","unstructured":"Veloo AC, van Winkelhoff AJ (2015) Antibiotic susceptibility profiles of anaerobic pathogens in the Netherlands. Anaerobe 31:19\u201324","journal-title":"Anaerobe"},{"issue":"1","key":"10730_CR9","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1093\/jac\/dkt344","volume":"69","author":"I Wybo","year":"2014","unstructured":"Wybo I, Van den Bossche D, Soetens O, Vekens E, Vandoorslaer K, Claeys G et al (2014) Fourth Belgian multicentre survey of antibiotic susceptibility of anaerobic bacteria. J Antimicrob Chemother 69(1):155\u2013161","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10730_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanmic.2024.07.010","volume":"6","author":"CS Ho","year":"2025","unstructured":"Ho CS, Wong CTH, Aung TT, Lakshminarayanan R, Mehta JS, Rauz S et al (2025) Antimicrobial resistance: a concise update. Lancet Microbe 6(1):100947","journal-title":"Lancet Microbe"},{"issue":"3","key":"10730_CR11","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.ijantimicag.2006.09.007","volume":"29","author":"E Urb\u00e1n","year":"2007","unstructured":"Urb\u00e1n E, Nagy E, P\u00e1l T, Sonnevend A, Conlon JM (2007) Activities of four frog skin-derived antimicrobial peptides (temporin-1DRa, temporin-1Va and the melittin-related peptides AR-23 and RV-23) against anaerobic bacteria. Int J Antimicrob Agents 29(3):317\u2013321","journal-title":"Int J Antimicrob Agents"},{"issue":"7","key":"10730_CR12","first-page":"3919","volume":"11","author":"J Lei","year":"2019","unstructured":"Lei J, Sun L, Huang S, Zhu C, Li P, He J et al (2019) The antimicrobial peptides and their potential clinical applications. Am J Transl Res 11(7):3919\u20133931","journal-title":"Am J Transl Res"},{"key":"10730_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/ph17111555","author":"HF Hetta","year":"2024","unstructured":"Hetta HF, Sirag N, Alsharif SM, Alharbi AA, Alkindy TT, Alkhamali A et al (2024) Antimicrobial peptides: the game-changer in the epic battle against multidrug-resistant bacteria. Pharmaceuticals (Basel). https:\/\/doi.org\/10.3390\/ph17111555","journal-title":"Pharmaceuticals (Basel)"},{"key":"10730_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21155460","author":"I Hansen","year":"2020","unstructured":"Hansen I, L\u00f6vdahl T, Simonovic D, Hansen K, Andersen AJC, Devold H et al (2020) Antimicrobial activity of small synthetic peptides based on the marine peptide turgencin A: prediction of antimicrobial peptide sequences in a natural peptide and strategy for optimization of potency. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21155460","journal-title":"Int J Mol Sci"},{"issue":"10","key":"10730_CR15","doi-asserted-by":"publisher","first-page":"5719","DOI":"10.1128\/AAC.02542-14","volume":"58","author":"S Nuding","year":"2014","unstructured":"Nuding S, Frasch T, Schaller M, Stange Eduard F, Zabel LT (2014) Synergistic effects of antimicrobial peptides and antibiotics against Clostridium difficile. Antimicrob Agents Chemother 58(10):5719\u20135725","journal-title":"Antimicrob Agents Chemother"},{"key":"10730_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare13050485","author":"S Restaino","year":"2025","unstructured":"Restaino S, Gomba B, Zero C, Stabile G, Ronsini C, Della Corte L et al (2025) Pelvic actinomycosis and diagnostic complexity: case report with literature review. Healthcare. https:\/\/doi.org\/10.3390\/healthcare13050485","journal-title":"Healthcare"},{"issue":"2","key":"10730_CR17","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1093\/jac\/dkv347","volume":"71","author":"C Steininger","year":"2016","unstructured":"Steininger C, Willinger B (2016) Resistance patterns in clinical isolates of pathogenic Actinomyces species. J Antimicrob Chemother 71(2):422\u2013427","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10730_CR18","volume":"17","author":"AA Ayantunde","year":"2025","unstructured":"Ayantunde AA, Kiang J, Raja NS, Ahmed J, Sanghera A, Venkatesha S, Ekwesianya AC (2025) Actinomyces species as emerging pathogens: an observational study of clinical infections and microbiological implications. Cureus 17(1):e77128","journal-title":"Cureus"},{"issue":"3","key":"10730_CR19","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1128\/JCM.42.3.1024-1029.2004","volume":"42","author":"S Joly","year":"2004","unstructured":"Joly S, Maze C, McCray PB Jr, Guthmiller JM (2004) Human beta-defensins 2 and 3 demonstrate strain-selective activity against oral microorganisms. J Clin Microbiol 42(3):1024\u20131029","journal-title":"J Clin Microbiol"},{"issue":"5","key":"10730_CR20","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/j.1600-0765.2006.00962.x","volume":"42","author":"S Ji","year":"2007","unstructured":"Ji S, Hyun J, Park E, Lee BL, Kim KK, Choi Y (2007) Susceptibility of various oral bacteria to antimicrobial peptides and to phagocytosis by neutrophils. J Periodontal Res 42(5):410\u2013419","journal-title":"J Periodontal Res"},{"issue":"11","key":"10730_CR21","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1016\/j.peptides.2010.07.016","volume":"31","author":"Z Tong","year":"2010","unstructured":"Tong Z, Dong L, Zhou L, Tao R, Ni L (2010) Nisin inhibits dental caries-associated microorganism in vitro. Peptides 31(11):2003\u20132008","journal-title":"Peptides"},{"issue":"1","key":"10730_CR22","doi-asserted-by":"publisher","DOI":"10.1080\/20002297.2020.1829405","volume":"12","author":"K Enigk","year":"2020","unstructured":"Enigk K, Jentsch H, Rodloff AC, Eschrich K, Stingu CS (2020) Activity of five antimicrobial peptides against periodontal as well as non-periodontal pathogenic strains. J Oral Microbiol 12(1):1829405","journal-title":"J Oral Microbiol"},{"issue":"2","key":"10730_CR23","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/j.1399-302X.2007.00389.x","volume":"23","author":"PL Weistroffer","year":"2008","unstructured":"Weistroffer PL, Joly S, Srikantha R, Tack BF, Brogden KA, Guthmiller JM (2008) SMAP29 congeners demonstrate activity against oral bacteria and reduced toxicity against oral keratinocytes. Oral Microbiol Immunol 23(2):89\u201395","journal-title":"Oral Microbiol Immunol"},{"key":"10730_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.anaerobe.2021.102439","volume":"71","author":"SN Wuersching","year":"2021","unstructured":"Wuersching SN, Huth KC, Hickel R, Kollmuss M (2021) Targeting antibiotic tolerance in anaerobic biofilms associated with oral diseases: human antimicrobial peptides LL-37 and lactoferricin enhance the antibiotic efficacy of amoxicillin, clindamycin and metronidazole. Anaerobe 71:102439","journal-title":"Anaerobe"},{"key":"10730_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.anaerobe.2020.102301","volume":"67","author":"SN Wuersching","year":"2021","unstructured":"Wuersching SN, Huth KC, Hickel R, Kollmuss M (2021) Inhibitory effect of LL-37 and human lactoferricin on growth and biofilm formation of anaerobes associated with oral diseases. Anaerobe 67:102301","journal-title":"Anaerobe"},{"issue":"6","key":"10730_CR26","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1007\/s12602-021-09830-3","volume":"13","author":"KS Caiaffa","year":"2021","unstructured":"Caiaffa KS, Dos Santos VR, Abuna GF, Santos-Filho NA, Cilli EM, Sakai VT et al (2021) Cytocompatibility and synergy of EGCG and cationic peptides against bacteria related to endodontic infections, in planktonic and biofilm conditions. Probiotics Antimicrob Proteins 13(6):1808\u20131819","journal-title":"Probiotics Antimicrob Proteins"},{"issue":"1","key":"10730_CR27","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1093\/jac\/dkl181","volume":"58","author":"H Altman","year":"2006","unstructured":"Altman H, Steinberg D, Porat Y, Mor A, Fridman D, Friedman M, Bachrach G (2006) In vitro assessment of antimicrobial peptides as potential agents against several oral bacteria. J Antimicrob Chemother 58(1):198\u2013201","journal-title":"J Antimicrob Chemother"},{"key":"10730_CR28","doi-asserted-by":"crossref","unstructured":"Helmerhorst EJ, Hodgson R, van \u2019t Hof W, Veerman EC, Allison C, Nieuw Amerongen AV ( 1999) The effects of histatin-derived basic antimicrobial peptides on oral biofilms. J Dent Res 78(6):1245\u20131250","DOI":"10.1177\/00220345990780060801"},{"key":"10730_CR29","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.peptides.2013.11.020","volume":"52","author":"Y Ding","year":"2014","unstructured":"Ding Y, Wang W, Fan M, Tong Z, Kuang R, Jiang W, Ni L (2014) Antimicrobial and anti-biofilm effect of Bac8c on major bacteria associated with dental caries and Streptococcus mutans biofilms. Peptides 52:61\u201367","journal-title":"Peptides"},{"issue":"2","key":"10730_CR30","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.peptides.2012.01.006","volume":"33","author":"W Wang","year":"2012","unstructured":"Wang W, Tao R, Tong Z, Ding Y, Kuang R, Zhai S et al (2012) Effect of a novel antimicrobial peptide chrysophsin-1 on oral pathogens and Streptococcus mutans biofilms. Peptides 33(2):212\u2013219","journal-title":"Peptides"},{"issue":"1","key":"10730_CR31","doi-asserted-by":"publisher","DOI":"10.1080\/20002297.2021.1943999","volume":"13","author":"J Luo","year":"2021","unstructured":"Luo J, Feng Z, Jiang W, Jiang X, Chen Y, Lv X, Zhang L (2021) Novel lactotransferrin-derived synthetic peptides suppress cariogenic bacteria in vitro and arrest dental caries in vivo: [Novel lactotransferrin-derived anticaries peptides]. J Oral Microbiol 13(1):1943999","journal-title":"J Oral Microbiol"},{"issue":"1","key":"10730_CR32","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ijantimicag.2010.08.014","volume":"37","author":"Y Liu","year":"2011","unstructured":"Liu Y, Wang L, Zhou X, Hu S, Zhang S, Wu H (2011) Effect of the antimicrobial decapeptide KSL on the growth of oral pathogens and Streptococcus mutans biofilm. Int J Antimicrob Agents 37(1):33\u201338","journal-title":"Int J Antimicrob Agents"},{"issue":"Pt 12","key":"10730_CR33","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1099\/jmm.0.05286-0","volume":"52","author":"SP Concannon","year":"2003","unstructured":"Concannon SP, Crowe TD, Abercrombie JJ, Molina CM, Hou P, Sukumaran DK et al (2003) Susceptibility of oral bacteria to an antimicrobial decapeptide. J Med Microbiol 52(Pt 12):1083\u20131093","journal-title":"J Med Microbiol"},{"issue":"2","key":"10730_CR34","doi-asserted-by":"publisher","first-page":"188","DOI":"10.3343\/alm.2022.42.2.188","volume":"42","author":"M Kim","year":"2022","unstructured":"Kim M, Yun SY, Lee Y, Lee H, Yong D, Lee K (2022) Clinical differences in patients infected with Fusobacterium and antimicrobial susceptibility of Fusobacterium isolates recovered at a tertiary-care hospital in Korea. Ann Lab Med 42(2):188\u2013195","journal-title":"Ann Lab Med"},{"issue":"12","key":"10730_CR35","volume":"11","author":"S Amini","year":"2024","unstructured":"Amini S, Meghjee S, Khan MR (2024) Lemierre\u2019s syndrome in a 16-year-old man associated with resolution of marked widespread ST elevation and a normal troponin level. Eur J Case Rep Intern Med 11(12):005062","journal-title":"Eur J Case Rep Intern Med"},{"issue":"6","key":"10730_CR36","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1093\/jac\/dki103","volume":"55","author":"K Ouhara","year":"2005","unstructured":"Ouhara K, Komatsuzawa H, Yamada S, Shiba H, Fujiwara T, Ohara M et al (2005) Susceptibilities of periodontopathogenic and cariogenic bacteria to antibacterial peptides, {beta}-defensins and LL37, produced by human epithelial cells. J Antimicrob Chemother 55(6):888\u2013896","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"10730_CR37","doi-asserted-by":"publisher","first-page":"3216","DOI":"10.1128\/AAC.45.11.3216-3219.2001","volume":"45","author":"JM Guthmiller","year":"2001","unstructured":"Guthmiller JM, Vargas KG, Srikantha R, Schomberg LL, Weistroffer PL, McCray PB Jr, Tack BF (2001) Susceptibilities of oral bacteria and yeast to mammalian cathelicidins. Antimicrob Agents Chemother 45(11):3216\u20133219","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"10730_CR38","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1902\/jop.2013.120679","volume":"84","author":"J Consuegra","year":"2013","unstructured":"Consuegra J, de Lima ME, Santos D, Sinisterra RD, Cort\u00e9s ME (2013) Peptides: \u03b2-cyclodextrin inclusion compounds as highly effective antimicrobial and anti-epithelial proliferation agents. J Periodontol 84(12):1858\u20131868","journal-title":"J Periodontol"},{"key":"10730_CR39","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.anaerobe.2014.08.001","volume":"30","author":"M Keskin","year":"2014","unstructured":"Keskin M, K\u00f6n\u00f6nen E, S\u00f6derling E, Isik G, Firatli E, Uitto VJ, G\u00fcrsoy UK (2014) Increased proliferation and decreased membrane permeability as defense mechanisms of Fusobacterium nucleatum against human neutrophilic peptide-1. Anaerobe 30:35\u201340","journal-title":"Anaerobe"},{"issue":"1","key":"10730_CR40","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1128\/AAC.49.1.183-187.2005","volume":"49","author":"CE Shelburne","year":"2005","unstructured":"Shelburne CE, Coulter WA, Olguin D, Lantz MS, Lopatin DE (2005) Induction of {beta}-defensin resistance in the oral anaerobe Porphyromonas gingivalis. Antimicrob Agents Chemother 49(1):183\u2013187","journal-title":"Antimicrob Agents Chemother"},{"key":"10730_CR41","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.regpep.2014.11.002","volume":"194\u2013195","author":"DT McLean","year":"2014","unstructured":"McLean DT, McCrudden MT, Linden GJ, Irwin CR, Conlon JM, Lundy FT (2014) Antimicrobial and immunomodulatory properties of PGLa-AM1, CPF-AM1, and magainin-AM1: potent activity against oral pathogens. Regul Pept 194\u2013195:63\u201368","journal-title":"Regul Pept"},{"issue":"2","key":"10730_CR42","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/bip.22605","volume":"104","author":"M Taniguchi","year":"2015","unstructured":"Taniguchi M, Ochiai A, Takahashi K, Nakamichi S, Nomoto T, Saitoh E et al (2015) Antimicrobial activity and mechanism of action of a novel cationic \u03b1-helical octadecapeptide derived from \u03b1-amylase of rice. Biopolymers 104(2):73\u201383","journal-title":"Biopolymers"},{"issue":"1","key":"10730_CR43","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1128\/AAC.44.1.68-72.2000","volume":"44","author":"H Oh","year":"2000","unstructured":"Oh H, Hedberg M, Wade D, Edlund C (2000) Activities of synthetic hybrid peptides against anaerobic bacteria: aspects of methodology and stability. Antimicrob Agents Chemother 44(1):68\u201372","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10730_CR44","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/j.1469-0691.1998.tb00666.x","volume":"4","author":"C Edlund","year":"1998","unstructured":"Edlund C, Hedberg M, Engstr\u00f6m A, Flock JI, Wade D (1998) Antianaerobic activity of a cecropin\u2013-melittin peptide. Clin Microbiol Infect 4(4):181\u2013185","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"10730_CR45","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1128\/AAC.43.4.782","volume":"43","author":"Y Ge","year":"1999","unstructured":"Ge Y, MacDonald DL, Holroyd KJ, Thornsberry C, Wexler H, Zasloff M (1999) In vitro antibacterial properties of pexiganan, an analog of magainin. Antimicrob Agents Chemother 43(4):782\u2013788","journal-title":"Antimicrob Agents Chemother"},{"key":"10730_CR46","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00246-17","author":"EJC Goldstein","year":"2017","unstructured":"Goldstein EJC, Citron DM, Tyrrell KL, Leoncio ES (2017) In vitro activity of pexiganan and 10 comparator antimicrobials against 234 isolates, including 93 Pasteurella species and 50 anaerobic bacterial isolates recovered from animal bite wounds. Antimicrob Agents Chemother. https:\/\/doi.org\/10.1128\/AAC.00246-17","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10730_CR47","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0732-8893(99)00056-5","volume":"35","author":"Y Ge","year":"1999","unstructured":"Ge Y, MacDonald D, Henry MM, Hait HI, Nelson KA, Lipsky BA et al (1999) In vitro susceptibility to pexiganan of bacteria isolated from infected diabetic foot ulcers. Diagn Microbiol Infect Dis 35(1):45\u201353","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10730_CR48","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01401-17","author":"EJC Goldstein","year":"2017","unstructured":"Goldstein EJC, Citron DM, Tyrrell KL, Leoncio ES (2017) In vitro activities of pexiganan and 10 comparator antimicrobials against 502 anaerobic isolates recovered from skin and skin structure infections. Antimicrob Agents Chemother. https:\/\/doi.org\/10.1128\/AAC.01401-17","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10730_CR49","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0924-8579(02)00275-3","volume":"21","author":"CA Genco","year":"2003","unstructured":"Genco CA, Maloy WL, Kari UP, Motley M (2003) Antimicrobial activity of magainin analogues against anaerobic oral pathogens. Int J Antimicrob Agents 21(1):75\u201378","journal-title":"Int J Antimicrob Agents"},{"key":"10730_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26164741","author":"J Toole","year":"2021","unstructured":"Toole J, Bolt HL, Marley JJ, Patrick S, Cobb SL, Lundy FT (2021) Peptoids with antibiofilm activity against the gram negative obligate anaerobe, Fusobacterium nucleatum. Molecules. https:\/\/doi.org\/10.3390\/molecules26164741","journal-title":"Molecules"},{"key":"10730_CR51","volume":"2018","author":"H Wang","year":"2018","unstructured":"Wang H, Ai L, Zhang Y, Cheng J, Yu H, Li C et al (2018) The effects of antimicrobial peptide Nal-P-113 on inhibiting periodontal pathogens and improving periodontal status. BioMed Res Int 2018:2018:1805793","journal-title":"BioMed Res Int"},{"key":"10730_CR52","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.actbio.2015.07.031","volume":"25","author":"HY Wang","year":"2015","unstructured":"Wang HY, Cheng JW, Yu HY, Lin L, Chih YH, Pan YP (2015) Efficacy of a novel antimicrobial peptide against periodontal pathogens in both planktonic and polymicrobial biofilm states. Acta Biomater 25:150\u2013161","journal-title":"Acta Biomater"},{"issue":"2","key":"10730_CR53","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1080\/02652048.2020.1842528","volume":"38","author":"Y Hu","year":"2021","unstructured":"Hu Y, Chen Y, Lin L, Zhang J, Lan R, Wu B (2021) Studies on antimicrobial peptide-loaded nanomaterial for root caries restorations to inhibit periodontitis related pathogens in periodontitis care. J Microencapsul 38(2):89\u201399","journal-title":"J Microencapsul"},{"issue":"5","key":"10730_CR54","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1128\/AAC.00924-06","volume":"51","author":"KF Novak","year":"2007","unstructured":"Novak KF, Diamond WJ, Kirakodu S, Peyyala R, Anderson KW, Montelaro RC, Mietzner TA (2007) Efficacy of the de novo-derived antimicrobial peptide WLBU2 against oral bacteria. Antimicrob Agents Chemother 51(5):1837\u20131839","journal-title":"Antimicrob Agents Chemother"},{"key":"10730_CR55","volume":"2015","author":"JY Li","year":"2015","unstructured":"Li JY, Wang XJ, Wang LN, Ying XX, Ren X, Liu HY et al (2015) High in vitro antibacterial activity of Pac-525 against Porphyromonas gingivalis biofilms cultured on titanium. Biomed Res Int 2015:909870","journal-title":"Biomed Res Int"},{"issue":"1","key":"10730_CR56","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s12602-009-9028-5","volume":"2","author":"CL Bratt","year":"2010","unstructured":"Bratt CL, Kohlgraf KG, Yohnke K, Kummet C, Dawson DV, Brogden KA (2010) Communication: antimicrobial activity of SMAP28 with a targeting domain for Porphyromonas gingivalis. Probiotics Antimicrob Proteins 2(1):21\u201325","journal-title":"Probiotics Antimicrob Proteins"},{"issue":"11","key":"10730_CR57","doi-asserted-by":"publisher","first-page":"4349","DOI":"10.1128\/JCM.40.11.4349-4352.2002","volume":"40","author":"KE Aldridge","year":"2002","unstructured":"Aldridge KE, O\u2019Brien M (2002) In vitro susceptibilities of the Bacteroides fragilis group species: change in isolation rates significantly affects overall susceptibility data. J Clin Microbiol 40(11):4349\u20134352","journal-title":"J Clin Microbiol"},{"key":"10730_CR58","unstructured":"Noor A, Khetarpal S (2025) Anaerobic Infections. Treasure Island (FL): StatPearls Publishing; [cited 2025 Jan]. Available from:\u00a0https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK482349\/. Accessed 14 Jan 2025"},{"issue":"1","key":"10730_CR59","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12941-021-00435-w","volume":"20","author":"S Jasemi","year":"2021","unstructured":"Jasemi S, Emaneini M, Ahmadinejad Z, Fazeli MS, Sechi LA, Sadeghpour Heravi F, Feizabadi MM (2021) Antibiotic resistance pattern of Bacteroides fragilis isolated from clinical and colorectal specimens. Ann Clin Microbiol Antimicrob 20(1):27","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10730_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens9110940","author":"GR Pricop","year":"2020","unstructured":"Pricop GR, Gheorghe I, Pircalabioru GG, Cristea V, Popa M, Marutescu L et al (2020) Resistance and virulence features of Bacteroides spp. isolated from abdominal infections in Romanian patients. Pathogens. https:\/\/doi.org\/10.3390\/pathogens9110940","journal-title":"Pathogens"},{"issue":"3","key":"10730_CR61","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.micinf.2009.01.001","volume":"11","author":"S Nuding","year":"2009","unstructured":"Nuding S, Zabel LT, Enders C, Porter E, Fellermann K, Wehkamp J et al (2009) Antibacterial activity of human defensins on anaerobic intestinal bacterial species: a major role of HBD-3. Microbes Infect 11(3):384\u2013393","journal-title":"Microbes Infect"},{"key":"10730_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.anaerobe.2020.102232","volume":"64","author":"JS de S\u00e1 Almeida","year":"2020","unstructured":"de S\u00e1 Almeida JS, de Oliveira Marre AT, Teixeira FL, Boente RF, Domingues R, de Paula GR, Lobo LA (2020) Lactoferrin and lactoferricin B reduce adhesion and biofilm formation in the intestinal symbionts Bacteroides fragilis and Bacteroides thetaiotaomicron. Anaerobe 64:102232","journal-title":"Anaerobe"},{"issue":"3","key":"10730_CR63","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1093\/jac\/dkg372","volume":"52","author":"A Arzese","year":"2003","unstructured":"Arzese A, Skerlavaj B, Tomasinsig L, Gennaro R, Zanetti M (2003) Antimicrobial activity of SMAP-29 against the Bacteroides fragilis group and clostridia. J Antimicrob Chemother 52(3):375\u2013381","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10730_CR64","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12866-017-1075-6","volume":"17","author":"B Durna\u015b","year":"2017","unstructured":"Durna\u015b B, Piktel E, W\u0105tek M, Wollny T, G\u00f3\u017ad\u017a S, Smok-Kalwat J et al (2017) Anaerobic bacteria growth in the presence of cathelicidin LL-37 and selected ceragenins delivered as magnetic nanoparticles cargo. BMC Microbiol 17(1):167","journal-title":"BMC Microbiol"},{"issue":"5","key":"10730_CR65","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1128\/AAC.42.5.1213","volume":"42","author":"PC Fuchs","year":"1998","unstructured":"Fuchs PC, Barry AL, Brown SD (1998) In vitro antimicrobial activity of MSI-78, a magainin analog. Antimicrob Agents Chemother 42(5):1213\u20131216","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10730_CR66","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1128\/AAC.01271-07","volume":"52","author":"G Bachrach","year":"2008","unstructured":"Bachrach G, Altman H, Kolenbrander PE, Chalmers NI, Gabai-Gutner M, Mor A et al (2008) Resistance of Porphyromonas gingivalis ATCC 33277 to direct killing by antimicrobial peptides is protease independent. Antimicrob Agents Chemother 52(2):638\u2013642","journal-title":"Antimicrob Agents Chemother"},{"key":"10730_CR67","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkaf458","author":"DG Hiregange","year":"2025","unstructured":"Hiregange DG, Samiya S, Mizgalska D, Ben-Zeev E, Waghalter M, Rivalta A et al (2025) Structural studies of ribosome from an anaerobic Bacteroidetes human pathogen Porphyromonas gingivalis. Nucleic Acids Res. https:\/\/doi.org\/10.1093\/nar\/gkaf458","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"10730_CR68","doi-asserted-by":"publisher","first-page":"5887","DOI":"10.1128\/AAC.05169-11","volume":"55","author":"H Maezono","year":"2011","unstructured":"Maezono H, Noiri Y, Asahi Y, Yamaguchi M, Yamamoto R, Izutani N et al (2011) Antibiofilm effects of azithromycin and erythromycin on Porphyromonas gingivalis. Antimicrob Agents Chemother 55(12):5887\u20135892","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10730_CR69","first-page":"501","volume":"23","author":"D Okuda","year":"2009","unstructured":"Okuda D, Yomogida S, Kuwahara-Arai K, Hitamatsu K, Tamura H, Nagaoka I (2009) Augmentation of the antimicrobial activities of guinea pig cathelicidin CAP11-derived peptides by amino acid substitutions. Int J Mol Med 23(4):501\u2013508","journal-title":"Int J Mol Med"},{"issue":"2","key":"10730_CR70","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1093\/jac\/dkl495","volume":"59","author":"CE Shelburne","year":"2007","unstructured":"Shelburne CE, An FY, Dholpe V, Ramamoorthy A, Lopatin DE, Lantz MS (2007) The spectrum of antimicrobial activity of the bacteriocin subtilosin A. J Antimicrob Chemother 59(2):297\u2013300","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10730_CR71","doi-asserted-by":"publisher","first-page":"21022","DOI":"10.1038\/s41598-021-00497-y","volume":"11","author":"X Lin","year":"2021","unstructured":"Lin X, Xu J, Shi Z, Xu Y, Fu T, Zhang L, He F (2021) Evaluation of the antibacterial effects and mechanism of Plantaricin 149 from Lactobacillus plantarum NRIC 149 on the peri-implantitis pathogens. Sci Rep 11(1):21022","journal-title":"Sci Rep"},{"key":"10730_CR72","doi-asserted-by":"publisher","DOI":"10.1002\/bip.23023","author":"M Taniguchi","year":"2017","unstructured":"Taniguchi M, Saito K, Nomoto T, Namae T, Ochiai A, Saitoh E, Tanaka T (2017) Identification and characterization of multifunctional cationic and amphipathic peptides from soybean proteins. Biopolymers. https:\/\/doi.org\/10.1002\/bip.23023","journal-title":"Biopolymers"},{"issue":"6","key":"10730_CR73","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.jbiosc.2016.05.008","volume":"122","author":"M Taniguchi","year":"2016","unstructured":"Taniguchi M, Ochiai A, Takahashi K, Nakamichi SI, Nomoto T, Saitoh E et al (2016) Antimicrobial activity against Porphyromonas gingivalis and mechanism of action of the cationic octadecapeptide AmyI-1-18 and its amino acid-substituted analogs. J Biosci Bioeng 122(6):652\u2013659","journal-title":"J Biosci Bioeng"},{"issue":"1","key":"10730_CR74","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/bip.22399","volume":"102","author":"M Taniguchi","year":"2014","unstructured":"Taniguchi M, Takahashi N, Takayanagi T, Ikeda A, Ishiyama Y, Saitoh E et al (2014) Effect of substituting arginine and lysine with alanine on antimicrobial activity and the mechanism of action of a cationic dodecapeptide (CL(14\u201325)), a partial sequence of cyanate lyase from rice. Biopolymers 102(1):58\u201368","journal-title":"Biopolymers"},{"issue":"6","key":"10730_CR75","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1093\/jac\/dkl120","volume":"57","author":"GX Wei","year":"2006","unstructured":"Wei GX, Campagna AN, Bobek LA (2006) Effect of MUC7 peptides on the growth of bacteria and on Streptococcus mutans biofilm. J Antimicrob Chemother 57(6):1100\u20131109","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"10730_CR76","doi-asserted-by":"publisher","first-page":"4125","DOI":"10.1128\/AAC.00208-07","volume":"51","author":"N Beckloff","year":"2007","unstructured":"Beckloff N, Laube D, Castro T, Furgang D, Park S, Perlin D et al (2007) Activity of an antimicrobial peptide mimetic against planktonic and biofilm cultures of oral pathogens. Antimicrob Agents Chemother 51(11):4125\u20134132","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"10730_CR77","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1007\/s00203-015-1126-z","volume":"197","author":"T Suwandecha","year":"2015","unstructured":"Suwandecha T, Srichana T, Balekar N, Nakpheng T, Pangsomboon K (2015) Novel antimicrobial peptide specifically active against Porphyromonas gingivalis. Arch Microbiol 197(7):899\u2013909","journal-title":"Arch Microbiol"},{"key":"10730_CR78","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.peptides.2012.12.015","volume":"42","author":"N Takei","year":"2013","unstructured":"Takei N, Takahashi N, Takayanagi T, Ikeda A, Hashimoto K, Takagi M et al (2013) Antimicrobial activity and mechanism of action of a novel cationic \u03b1-helical dodecapeptide, a partial sequence of cyanate lyase from rice. Peptides 42:55\u201362","journal-title":"Peptides"},{"key":"10730_CR79","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.peptides.2017.09.019","volume":"97","author":"M Taniguchi","year":"2017","unstructured":"Taniguchi M, Kawabe J, Toyoda R, Namae T, Ochiai A, Saitoh E, Tanaka T (2017) Cationic peptides from peptic hydrolysates of rice endosperm protein exhibit antimicrobial, LPS-neutralizing, and angiogenic activities. Peptides 97:70\u201378","journal-title":"Peptides"},{"key":"10730_CR80","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11070888","author":"Y Castillo","year":"2022","unstructured":"Castillo Y, Delgadillo NA, Neuta Y, Hern\u00e1ndez A, Acevedo T, C\u00e1rdenas E et al (2022) Antibiotic susceptibility and resistance genes in oral clinical isolates of Prevotella intermedia, Prevotella nigrescens, and Prevotella melaninogenica. Antibiotics. https:\/\/doi.org\/10.3390\/antibiotics11070888","journal-title":"Antibiotics"},{"issue":"2","key":"10730_CR81","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/S0014-4800(02)00022-9","volume":"74","author":"B Yasin","year":"2003","unstructured":"Yasin B, Pang M, Lehrer RI, Wagar EA (2003) Activity of Novispirin G-10, a novel antimicrobial peptide against Chlamydia trachomatis and vaginosis-associated bacteria. Exp Mol Pathol 74(2):190\u2013195","journal-title":"Exp Mol Pathol"},{"key":"10730_CR82","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.ARBA-0020-2017","author":"M Archambault","year":"2020","unstructured":"Archambault M, Rubin JE (2020) Antimicrobial resistance in Clostridium and Brachyspira spp. and other anaerobes. Microbiol Spectr. https:\/\/doi.org\/10.1128\/microbiolspec.ARBA-0020-2017","journal-title":"Microbiol Spectr"},{"issue":"4","key":"10730_CR83","first-page":"138","volume":"88","author":"C Xu","year":"2024","unstructured":"Xu C, She Y, Fu F, Xu C, Peng K (2024) Review of advances in molecular structure and biological function of alpha toxin of Clostridium perfringens. Can J Vet Res 88(4):138\u2013144","journal-title":"Can J Vet Res"},{"key":"10730_CR84","doi-asserted-by":"publisher","unstructured":"Olleik H, Nicoletti C, Lafond M, Courvoisier-Dezord E, Xue P, Hijazi A et al (2019) Comparative structure-activity analysis of the antimicrobial activity, cytotoxicity, and mechanism of action of the fungal cyclohexadepsipeptides enniatins and beauvericin. Toxins (Basel). https:\/\/doi.org\/10.3390\/toxins11090514","DOI":"10.3390\/toxins11090514"},{"issue":"1","key":"10730_CR85","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.anaerobe.2006.09.006","volume":"13","author":"TG Yudina","year":"2007","unstructured":"Yudina TG, Brioukhanov AL, Zalunin IA, Revina LP, Shestakov AI, Voyushina NE et al (2007) Antimicrobial activity of different proteins and their fragments from Bacillus thuringiensis parasporal crystals against clostridia and archaea. Anaerobe 13(1):6\u201313","journal-title":"Anaerobe"},{"issue":"4","key":"10730_CR86","doi-asserted-by":"publisher","first-page":"e00529","DOI":"10.1128\/JB.00529-19","volume":"202","author":"I Sugrue","year":"2020","unstructured":"Sugrue I, O\u2019Connor PM, Hill C, Stanton C, Ross RP (2020) Actinomyces produces defensin-like bacteriocins (Actifensins) with a highly degenerate structure and broad antimicrobial activity. J Bacteriol 202(4):e00529","journal-title":"J Bacteriol"},{"issue":"9","key":"10730_CR87","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1016\/j.biochi.2011.05.001","volume":"93","author":"EH Crost","year":"2011","unstructured":"Crost EH, Ajandouz EH, Villard C, Geraert PA, Puigserver A, Fons M (2011) Ruminococcin C, a new anti-Clostridium perfringens bacteriocin produced in the gut by the commensal bacterium Ruminococcus gnavus E1. Biochimie 93(9):1487\u20131494","journal-title":"Biochimie"},{"issue":"11","key":"10730_CR88","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1002\/bmc.2948","volume":"27","author":"V Vidhyasagar","year":"2013","unstructured":"Vidhyasagar V, Jeevaratnam K (2013) Bacteriocin activity against various pathogens produced by Pediococcus pentosaceus VJ13 isolated from Idly batter. Biomed Chromatogr 27(11):1497\u20131502","journal-title":"Biomed Chromatogr"},{"key":"10730_CR89","doi-asserted-by":"publisher","first-page":"396304","DOI":"10.1155\/2014\/396304","volume":"2014","author":"AM Embaby","year":"2014","unstructured":"Embaby AM, Heshmat Y, Hussein A, Marey HS (2014) A sequential statistical approach towards an optimized production of a broad spectrum bacteriocin substance from a soil bacterium Bacillus sp. YAS 1 strain. ScientificWorldJournal 2014:396304","journal-title":"ScientificWorldJournal"},{"issue":"4","key":"10730_CR90","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1159\/000223069","volume":"55","author":"MD Sparo","year":"2009","unstructured":"Sparo MD, Jones DG, S\u00e1nchez Bruni SF (2009) Assessment of the in vitro efficacy of the novel antimicrobial peptide CECT7121 against human Gram-positive bacteria from serious infections refractory to treatment. Chemotherapy 55(4):270\u2013277","journal-title":"Chemotherapy"},{"issue":"4","key":"10730_CR91","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1128\/AAC.31.4.625","volume":"31","author":"RN Jones","year":"1987","unstructured":"Jones RN, Barry AL (1987) Antimicrobial activity and spectrum of LY146032, a lipopeptide antibiotic, including susceptibility testing recommendations. Antimicrob Agents Chemother 31(4):625\u2013629","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10730_CR92","doi-asserted-by":"publisher","first-page":"5045","DOI":"10.1007\/s00253-016-7387-x","volume":"100","author":"L Zong","year":"2016","unstructured":"Zong L, Teng D, Wang X, Mao R, Yang N, Hao Y, Wang J (2016) Mechanism of action of a novel recombinant peptide, MP1102, against Clostridium perfringens type C. Appl Microbiol Biotechnol 100(11):5045\u20135057","journal-title":"Appl Microbiol Biotechnol"},{"issue":"9","key":"10730_CR93","doi-asserted-by":"publisher","first-page":"e0185215","DOI":"10.1371\/journal.pone.0185215","volume":"12","author":"X Zheng","year":"2017","unstructured":"Zheng X, Wang X, Teng D, Mao R, Hao Y, Yang N et al (2017) Mode of action of plectasin-derived peptides against gas gangrene-associated Clostridium perfringens type A. PLoS ONE 12(9):e0185215","journal-title":"PLoS ONE"},{"issue":"3","key":"10730_CR94","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1128\/AAC.00568-06","volume":"51","author":"A van Dijk","year":"2007","unstructured":"van Dijk A, Veldhuizen EJ, Kalkhove SI, Tjeerdsma-van Bokhoven JL, Romijn RA, Haagsman HP (2007) The beta-defensin gallinacin-6 is expressed in the chicken digestive tract and has antimicrobial activity against food-borne pathogens. Antimicrob Agents Chemother 51(3):912\u2013922","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10730_CR95","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1086\/421558","volume":"39","author":"DW Hecht","year":"2004","unstructured":"Hecht DW (2004) Prevalence of antibiotic resistance in anaerobic bacteria: worrisome developments. Clin Infect Dis 39(1):92\u201397","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10730_CR96","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.anaerobe.2012.09.004","volume":"18","author":"R McQuade","year":"2012","unstructured":"McQuade R, Roxas B, Viswanathan VK, Vedantam G (2012) Clostridium difficile clinical isolates exhibit variable susceptibility and proteome alterations upon exposure to mammalian cationic antimicrobial peptides. Anaerobe 18(6):614\u2013620","journal-title":"Anaerobe"},{"issue":"1","key":"10730_CR97","doi-asserted-by":"publisher","first-page":"30","DOI":"10.4014\/jmb.1809.08065","volume":"29","author":"IN Yoon","year":"2019","unstructured":"Yoon IN, Hwang JS, Lee JH, Kim H (2019) The antimicrobial peptide CopA3 inhibits Clostridium difficile toxin A-induced viability loss and apoptosis in neural cells. J Microbiol Biotechnol 29(1):30\u201336","journal-title":"J Microbiol Biotechnol"},{"issue":"10","key":"10730_CR98","doi-asserted-by":"publisher","first-page":"4850","DOI":"10.1128\/AAC.00177-11","volume":"55","author":"JK Kang","year":"2011","unstructured":"Kang JK, Hwang JS, Nam HJ, Ahn KJ, Seok H, Kim SK et al (2011) The insect peptide coprisin prevents Clostridium difficile-mediated acute inflammation and mucosal damage through selective antimicrobial activity. Antimicrob Agents Chemother 55(10):4850\u20134857","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10730_CR99","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1002\/psc.3046","volume":"23","author":"IN Yoon","year":"2017","unstructured":"Yoon IN, Lu LF, Hong J, Zhang P, Kim DH, Kang JK et al (2017) The American cockroach peptide periplanetasin-4 inhibits Clostridium difficile toxin A-induced cell toxicities and inflammatory responses in the mouse gut. J Pept Sci 23(11):833\u2013839","journal-title":"J Pept Sci"},{"issue":"4","key":"10730_CR100","doi-asserted-by":"publisher","first-page":"694","DOI":"10.4014\/jmb.1612.12012","volume":"27","author":"J Hong","year":"2017","unstructured":"Hong J, Zhang P, Yoon IN, Hwang JS, Kang JK, Kim H (2017) The American cockroach peptide periplanetasin-2 blocks Clostridium difficile toxin A-induced cell damage and inflammation in the gut. J Microbiol Biotechnol 27(4):694\u2013700","journal-title":"J Microbiol Biotechnol"},{"issue":"3","key":"10730_CR101","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.ijantimicag.2009.11.017","volume":"35","author":"H Mkrtchyan","year":"2010","unstructured":"Mkrtchyan H, Gibbons S, Heidelberger S, Zloh M, Limaki HK (2010) Purification, characterisation and identification of acidocin LCHV, an antimicrobial peptide produced by Lactobacillus acidophilus n.v. Er 317\/402 strain Narine. Int J Antimicrob Agents 35(3):255\u2013260","journal-title":"Int J Antimicrob Agents"},{"issue":"20","key":"10730_CR102","doi-asserted-by":"publisher","first-page":"9352","DOI":"10.1073\/pnas.0913554107","volume":"107","author":"MC Rea","year":"2010","unstructured":"Rea MC, Sit CS, Clayton E, O\u2019Connor PM, Whittal RM, Zheng J et al (2010) Thuricin CD, a posttranslationally modified bacteriocin with a narrow spectrum of activity against Clostridium difficile. Proc Natl Acad Sci U S A 107(20):9352\u20139357","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10730_CR103","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/j.1751-7915.2010.00184.x","volume":"3","author":"D Field","year":"2010","unstructured":"Field D, Quigley L, O\u2019Connor PM, Rea MC, Daly K, Cotter PD et al (2010) Studies with bioengineered nisin peptides highlight the broad-spectrum potency of nisin V. Microb Biotechnol 3(4):473\u2013486","journal-title":"Microb Biotechnol"},{"key":"10730_CR104","doi-asserted-by":"publisher","first-page":"3104613","DOI":"10.1155\/2020\/3104613","volume":"2020","author":"J Lv","year":"2020","unstructured":"Lv J, Da R, Cheng Y, Tuo X, Wei J, Jiang K et al (2020) Mechanism of antibacterial activity of Bacillus amyloliquefaciens C-1 lipopeptide toward anaerobic Clostridium difficile. Biomed Res Int 2020:3104613","journal-title":"Biomed Res Int"},{"issue":"9","key":"10730_CR105","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0257431","volume":"16","author":"S Arthithanyaroj","year":"2021","unstructured":"Arthithanyaroj S, Chankhamhaengdecha S, Chaisri U, Aunpad R, Aroonnual A (2021) Effective inhibition of Clostridioides difficile by the novel peptide CM-A. PLoS ONE 16(9):e0257431","journal-title":"PLoS ONE"},{"issue":"5","key":"10730_CR106","doi-asserted-by":"publisher","first-page":"468","DOI":"10.4103\/1735-5362.383703","volume":"18","author":"A Shahali","year":"2023","unstructured":"Shahali A, Soltani R, Akbari V (2023) Probiotic Lactobacillus and the potential risk of spreading antibiotic resistance: a systematic review. Res Pharm Sci 18(5):468\u2013477","journal-title":"Res Pharm Sci"},{"issue":"5","key":"10730_CR107","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1271\/bbb.110972","volume":"76","author":"N Ishibashi","year":"2012","unstructured":"Ishibashi N, Himeno K, Fujita K, Masuda Y, Perez RH, Zendo T et al (2012) Purification and characterization of multiple bacteriocins and an inducing peptide produced by Enterococcus faecium NKR-5-3 from Thai fermented fish. Biosci Biotechnol Biochem 76(5):947\u2013953","journal-title":"Biosci Biotechnol Biochem"},{"issue":"1","key":"10730_CR108","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s12010-016-2328-9","volume":"182","author":"F Meng","year":"2017","unstructured":"Meng F, Zhu X, Lu F, Bie X, Lu Z (2017) Functional analysis of plantaricin E and its mutant by heterologous expression in Escherichia coli. Appl Biochem Biotechnol 182(1):311\u2013323","journal-title":"Appl Biochem Biotechnol"},{"issue":"2","key":"10730_CR109","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.bbamem.2015.11.018","volume":"1858","author":"X Zhang","year":"2016","unstructured":"Zhang X, Wang Y, Liu L, Wei Y, Shang N, Zhang X, Li P (2016) Two-peptide bacteriocin PlnEF causes cell membrane damage to Lactobacillus plantarum. Biochim Biophys Acta 1858(2):274\u2013280","journal-title":"Biochim Biophys Acta"},{"key":"10730_CR110","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.pep.2015.11.008","volume":"119","author":"F Meng","year":"2016","unstructured":"Meng F, Zhao H, Zhang C, Lu F, Bie X, Lu Z (2016) Expression of a novel bacteriocin-the plantaricin Pln1-in Escherichia coli and its functional analysis. Protein Expr Purif 119:85\u201393","journal-title":"Protein Expr Purif"},{"issue":"24","key":"10730_CR111","doi-asserted-by":"publisher","first-page":"22945","DOI":"10.1074\/jbc.M501620200","volume":"280","author":"PE Kristiansen","year":"2005","unstructured":"Kristiansen PE, Fimland G, Mantzilas D, Nissen-Meyer J (2005) Structure and mode of action of the membrane-permeabilizing antimicrobial peptide pheromone plantaricin A. J Biol Chem 280(24):22945\u201322950","journal-title":"J Biol Chem"},{"issue":"46","key":"10730_CR112","doi-asserted-by":"publisher","first-page":"16026","DOI":"10.1021\/bi981532j","volume":"37","author":"HH Hauge","year":"1998","unstructured":"Hauge HH, Mantzilas D, Moll GN, Konings WN, Driessen AJ, Eijsink VG, Nissen-Meyer J (1998) Plantaricin A is an amphiphilic alpha-helical bacteriocin-like pheromone which exerts antimicrobial and pheromone activities through different mechanisms. Biochemistry 37(46):16026\u201316032","journal-title":"Biochemistry"},{"issue":"10","key":"10730_CR113","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1039\/C4FO00481G","volume":"5","author":"D Das","year":"2014","unstructured":"Das D, Goyal A (2014) Characterization of a noncytotoxic bacteriocin from probiotic Lactobacillus plantarum DM5 with potential as a food preservative. Food Funct 5(10):2453\u20132462","journal-title":"Food Funct"},{"issue":"7","key":"10730_CR114","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1007\/s12010-012-0044-7","volume":"169","author":"PK Jena","year":"2013","unstructured":"Jena PK, Trivedi D, Chaudhary H, Sahoo TK, Seshadri S (2013) Bacteriocin PJ4 active against enteric pathogen produced by Lactobacillus helveticus PJ4 isolated from gut microflora of wistar rat (Rattus norvegicus): partial purification and characterization of bacteriocin. Appl Biochem Biotechnol 169(7):2088\u20132100","journal-title":"Appl Biochem Biotechnol"},{"key":"10730_CR115","doi-asserted-by":"publisher","DOI":"10.1128\/AEM.01519-17","author":"J Lozo","year":"2017","unstructured":"Lozo J, Mirkovic N, O\u2019Connor PM, Malesevic M, Miljkovic M, Polovic N et al (2017) Lactolisterin BU, a novel class II broad-spectrum bacteriocin from Lactococcus lactis subsp. lactis bv. diacetylactis BGBU1-4. Appl Environ Microbiol. https:\/\/doi.org\/10.1128\/AEM.01519-17","journal-title":"Appl Environ Microbiol"},{"issue":"22","key":"10730_CR116","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1080\/14786419.2014.996754","volume":"29","author":"XF Wang","year":"2015","unstructured":"Wang XF, Tian F, Cao RM, Li J, Wu SM, Guo XK, Chen TX (2015) Antimicrobial activity of human \u03b2-defensins against lactic acid bacteria. Nat Prod Res 29(22):2164\u20132166","journal-title":"Nat Prod Res"},{"issue":"10","key":"10730_CR117","doi-asserted-by":"publisher","first-page":"3349","DOI":"10.1128\/AAC.47.10.3349-3351.2003","volume":"47","author":"G Maisetta","year":"2003","unstructured":"Maisetta G, Batoni G, Esin S, Luperini F, Pardini M, Bottai D et al (2003) Activity of human beta-defensin 3 alone or combined with other antimicrobial agents against oral bacteria. Antimicrob Agents Chemother 47(10):3349\u20133351","journal-title":"Antimicrob Agents Chemother"},{"issue":"13","key":"10730_CR118","doi-asserted-by":"publisher","first-page":"3649","DOI":"10.1128\/JB.184.13.3649-3656.2002","volume":"184","author":"T Faye","year":"2002","unstructured":"Faye T, Brede DA, Langsrud T, Nes IF, Holo H (2002) An antimicrobial peptide is produced by extracellular processing of a protein from Propionibacterium jensenii. J Bacteriol 184(13):3649\u20133656","journal-title":"J Bacteriol"},{"issue":"4","key":"10730_CR119","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1007\/s11274-013-1558-z","volume":"30","author":"B Alkotaini","year":"2014","unstructured":"Alkotaini B, Anuar N, Kadhum AA, Sani AA (2014) Isolation and identification of a new intracellular antimicrobial peptide produced by Paenibacillus alvei AN5. World J Microbiol Biotechnol 30(4):1377\u20131385","journal-title":"World J Microbiol Biotechnol"},{"issue":"3","key":"10730_CR120","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.fm.2008.11.003","volume":"26","author":"M Enrique","year":"2009","unstructured":"Enrique M, Manzanares P, Yuste M, Mart\u00ednez M, Vall\u00e9s S, Marcos JF (2009) Selectivity and antimicrobial action of bovine lactoferrin derived peptides against wine lactic acid bacteria. Food Microbiol 26(3):340\u2013346","journal-title":"Food Microbiol"},{"issue":"1","key":"10730_CR121","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1590\/0001-3765201520130511","volume":"87","author":"LF Leandro","year":"2015","unstructured":"Leandro LF, Mendes CA, Casemiro LA, Vinholis AH, Cunha WR, de Almeida R, Martins CH (2015) Antimicrobial activity of apitoxin, melittin and phospholipase A\u2082 of honey bee (Apis mellifera) venom against oral pathogens. An Acad Bras Cienc 87(1):147\u2013155","journal-title":"An Acad Bras Cienc"},{"issue":"12","key":"10730_CR122","doi-asserted-by":"publisher","first-page":"5487","DOI":"10.1007\/s00253-014-5560-7","volume":"98","author":"Z Peng","year":"2014","unstructured":"Peng Z, Wang A, Feng Q, Wang Z, Ivanova IV, He X et al (2014) High-level expression, purification and characterisation of porcine \u03b2-defensin 2 in Pichia pastoris and its potential as a cost-efficient growth promoter in porcine feed. Appl Microbiol Biotechnol 98(12):5487\u20135497","journal-title":"Appl Microbiol Biotechnol"},{"key":"10730_CR123","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.00537","volume":"11","author":"S Chou","year":"2020","unstructured":"Chou S, Li Q, Nina Z, Shang L, Li J, Li J et al (2020) Peptides with triplet-tryptophan-pivot promoted pathogenic bacteria membrane defects. Front Microbiol 11:537","journal-title":"Front Microbiol"},{"key":"10730_CR124","doi-asserted-by":"publisher","DOI":"10.1038\/srep38410","volume":"6","author":"ZB Huang","year":"2016","unstructured":"Huang ZB, Shi X, Mao J, Gong SQ (2016) Design of a hydroxyapatite-binding antimicrobial peptide with improved retention and antibacterial efficacy for oral pathogen control. Sci Rep 6:38410","journal-title":"Sci Rep"},{"issue":"7","key":"10730_CR125","doi-asserted-by":"publisher","DOI":"10.1002\/psc.3255","volume":"26","author":"Y Wu","year":"2020","unstructured":"Wu Y, Zhang G, Zhou M (2020) Inhibitory and anti-inflammatory effects of two antimicrobial peptides moronecidin and temporin-1Dra against Propionibacterium acnesin vitro and in vivo. J Pept Sci 26(7):e3255","journal-title":"J Pept Sci"},{"issue":"2","key":"10730_CR126","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.peptides.2012.02.010","volume":"34","author":"S Popovic","year":"2012","unstructured":"Popovic S, Urb\u00e1n E, Lukic M, Conlon JM (2012) Peptides with antimicrobial and anti-inflammatory activities that have therapeutic potential for treatment of acne vulgaris. Peptides 34(2):275\u2013282","journal-title":"Peptides"},{"key":"10730_CR127","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.788358","volume":"12","author":"J Wu","year":"2021","unstructured":"Wu J, Guo R, Chai J, Xiong W, Tian M, Lu W, Xu X (2021) The protective effects of Cath-MH with anti-propionibacterium acnes and anti-inflammation functions on acne vulgaris. Front Pharmacol 12:788358","journal-title":"Front Pharmacol"},{"issue":"5","key":"10730_CR128","doi-asserted-by":"publisher","first-page":"707","DOI":"10.4014\/jmb.1802.02027","volume":"28","author":"W Phupiewkham","year":"2018","unstructured":"Phupiewkham W, Lu Q, Payoungkiattikun W, Temsiripong T, Jangpromma N, Lai R, Klaynongsruang S (2018) Development and characterization of an anti-acne gel containing Siamese crocodile (Crocodylus siamensis) leukocyte extract. J Microbiol Biotechnol 28(5):707\u2013717","journal-title":"J Microbiol Biotechnol"},{"key":"10730_CR129","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.peptides.2017.11.001","volume":"99","author":"R Han","year":"2018","unstructured":"Han R, Blencke HM, Cheng H, Li C (2018) The antimicrobial effect of CEN1HC-Br against Propionibacterium acnes and its therapeutic and anti-inflammatory effects on acne vulgaris. Peptides 99:36\u201343","journal-title":"Peptides"},{"issue":"6","key":"10730_CR130","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1111\/bjd.13480","volume":"171","author":"S Ryu","year":"2014","unstructured":"Ryu S, Park Y, Kim B, Cho SM, Lee J, Lee HH et al (2014) Inhibitory and anti-inflammatory effects of the Helicobacter pylori-derived antimicrobial peptide HPA3NT3 against Propionibacterium acnes in the skin. Br J Dermatol 171(6):1358\u20131367","journal-title":"Br J Dermatol"},{"issue":"7","key":"10730_CR131","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0022120","volume":"6","author":"Y Wang","year":"2011","unstructured":"Wang Y, Zhang Z, Chen L, Guang H, Li Z, Yang H et al (2011) Cathelicidin-BF, a snake cathelicidin-derived antimicrobial peptide, could be an excellent therapeutic agent for acne vulgaris. PLoS ONE 6(7):e22120","journal-title":"PLoS ONE"},{"issue":"6","key":"10730_CR132","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/j.peptides.2009.02.006","volume":"30","author":"CY Pan","year":"2009","unstructured":"Pan CY, Chen JY, Lin TL, Lin CH (2009) In vitro activities of three synthetic peptides derived from epinecidin-1 and an anti-lipopolysaccharide factor against Propionibacterium acnes, Candida albicans, and Trichomonas vaginalis. Peptides 30(6):1058\u20131068","journal-title":"Peptides"},{"issue":"8","key":"10730_CR133","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0072923","volume":"8","author":"Z Zhang","year":"2013","unstructured":"Zhang Z, Mu L, Tang J, Duan Z, Wang F, Wei L et al (2013) A small peptide with therapeutic potential for inflammatory acne vulgaris. PLoS ONE 8(8):e72923","journal-title":"PLoS ONE"},{"key":"10730_CR134","doi-asserted-by":"publisher","DOI":"10.1002\/mabi.201700090","author":"SS Nair","year":"2017","unstructured":"Nair SS, Zolotarskaya OY, Beckwith MJ, Ohman DE, Wynne KJ (2017) A polycation antimicrobial peptide mimic without resistance buildup against Propionibacterium acnes. Macromol Biosci. https:\/\/doi.org\/10.1002\/mabi.201700090","journal-title":"Macromol Biosci"},{"issue":"7","key":"10730_CR135","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0132619","volume":"10","author":"S Ryu","year":"2015","unstructured":"Ryu S, Han HM, Song PI, Armstrong CA, Park Y (2015) Suppression of Propionibacterium acnes infection and the associated inflammatory response by the antimicrobial peptide P5 in mice. PLoS ONE 10(7):e0132619","journal-title":"PLoS ONE"},{"key":"10730_CR136","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2025.1517154","volume":"15","author":"Z Cui","year":"2025","unstructured":"Cui Z, Wang P, Gao W (2025) Microbial dysbiosis in periodontitis and peri-implantitis: pathogenesis, immune responses, and therapeutic. Front Cell Infect Microbiol 15:1517154","journal-title":"Front Cell Infect Microbiol"}],"container-title":["Probiotics and Antimicrobial Proteins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-025-10730-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12602-025-10730-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-025-10730-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T10:03:16Z","timestamp":1778752996000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12602-025-10730-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,9]]},"references-count":136,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10730"],"URL":"https:\/\/doi.org\/10.1007\/s12602-025-10730-z","relation":{},"ISSN":["1867-1306","1867-1314"],"issn-type":[{"value":"1867-1306","type":"print"},{"value":"1867-1314","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,9]]},"assertion":[{"value":"9 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This was a review study; ethical approval was not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}